For this reason, in order to demonstrate that DSF treatment may inhibits IL-8-dependent pathways, that it has been previously demonstrated active in our experimental model of neuropathic pain [21], differentiated F11 cells have been treated with GRO/KC (the murine analogous of IL-8) in place of Paclitaxel. Here, CXCL8 is linked to neuropathic pain.